In This Article:
Cardio Diagnostics Holdings (NASDAQ:CDIO) Full Year 2024 Results
Key Financial Results
-
Net loss: US$8.38m (flat on FY 2023).
-
US$0.31 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cardio Diagnostics Holdings EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 37%. Earnings per share (EPS) exceeded analyst estimates by 14%.
The company's shares are up 6.1% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 6 warning signs for Cardio Diagnostics Holdings (of which 4 are significant!) you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.